Delivery Order SPE2DB24D2205-SPE2DB25FEHDY
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $69K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Orilissa 150mg tablets (28-count packages) under a firm fixed-price contract valued at $10,105.73. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 3, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,321.58 delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity: 7 units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) under a firm fixed price contract valued at $2,280.66. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $2,491.20 delivery order to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count package) under a firm fixed price contract type. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive delivery order supporting the federal government's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $6,308.10 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Orilissa 150 mg tablets (7-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of July 21, 2025, and performance in Conshohocken, Pennsylvania. Orilissa is an endometriosis treatment medication, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely supplies to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,143.08 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (7-count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Orilissa 150 mg tablets (seven-count packages) under a firm fixed-price contract valued at $4,756.11, with completion scheduled for September 8, 2025. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Orilissa 200 mg tablets in quantities of 14 units, with a ceiling value of $10,900.19. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The contract was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, and has an ultimate completion date of May 21, 2025. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,493.91 to AmerisourceBergen Drug Corp for 7 tablets of Orilissa 150 mg on September 8, 2025, with a completion date of September 9, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a procurement of the endometriosis medication Orilissa to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...